Investor Overview Press Releases January 6, 2023 Aclaris Therapeutics Provides 2023 Outlook November 29, 2022 Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China November 22, 2022 Aclaris Therapeutics Announces Key Leadership Transitions View all » Events Jan 11, 20235:15 PM EST Aclaris Therapeutics at 41st Annual J.P. Morgan Healthcare Conference Nov 29, 20229:30 AM EST Aclaris Therapeutics at 34th Annual Piper Sandler Healthcare Conference Nov 16, 20225:00 PM GMT Aclaris Therapeutics at Jefferies London Healthcare Conference View all » Feature Presentation Aclaris Therapeutics Company Overview – January 2023
November 29, 2022 Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China